GE HealthCare will showcase next-generation technologies at ISMRM 2026, including a helium-free 1.5T MR system, advanced 3T scanner, and AI-powered workflows. Its advanced MR research tools are designed to simplify collaboration and accelerate innovation.
At the ISMRM 2026 Annual Meeting, GE HealthCare announced new advancements in MR systems and research tools aimed at accelerating innovation, improving collaboration, and supporting clinical breakthroughs. The company’s next-generation SIGNA MR technologies combine advanced hardware, AI-powered software, and deep learning capabilities to help reduce scan times, enhance image quality, and deliver more consistent research data across studies and locations.
Kelly Londy, President & CEO of MR and Women’s Health at GE HealthCare, stated that the company’s focus is to empower researchers with advanced tools and collaborative resources that help speed discoveries and expand clinical impact.
Driving the future of MR with AI-powered technologies
Building on its leadership in AI-enabled medical imaging, GE HealthCare announced the U.S. FDA 510(k) pending status for Sonic DL, its latest deep-learning acceleration technology for 2D MR imaging beyond cardiac applications. The enhanced solution is expected to benefit up to 85% of MR exams by reducing scan times while improving image quality and signal-to-noise ratio.
At the core of GE HealthCare’s latest MR innovations is SIGNA One, an AI-powered workflow platform designed to simplify MRI operations, improve efficiency, and deliver more consistent imaging across clinical and research settings. The platform includes AI-guided workflows, reduced training complexity, and seamless switching between clinical and research modes.
Built on this platform, the 510(k)-cleared SIGNA Bolt 3T MRI system combines deep-learning technology, high-performance imaging, and sustainability-focused design to support precision diagnostics and efficient operations.
GE HealthCare also introduced SIGNA Sprint with Freelium, a helium-free MR technology designed to reduce helium dependency while maintaining image quality and operational efficiency.
In addition, AIR Recon DL now supports Zero Echo Time (ZTE) and Silenz low-noise imaging, helping improve image quality, shorten scan times, and expand applications such as bone and lung imaging without ionizing radiation.
Enhancing research collaboration with next-generation MR tools
GE HealthCare will introduce SIGNA Studio, a new suite of software development and collaboration tools designed to make MR research more efficient, accessible, and easier to deploy.
Advancing neuroscience research with innovative MR technology
Building on existing research collaborations, GE HealthCare announced two new installations of its investigational MAGNUS prototype head-only MR scanner at King’s College London and West China Hospital. The advanced system is designed to support breakthroughs in neuroscience research, including microstructural imaging, advanced diffusion, and functional imaging techniques powered by Sonic DL and AIR Recon DL technologies.
Dr. Steve Williams of King’s College London stated that the platform enables researchers to study brain structure and function in greater detail, helping expand understanding of neurological diseases and opening new research opportunities.
GE HealthCare also continues to enhance neurological care through the integration of icometrix and its icobrain platform, supporting advanced brain MRI analysis and more personalized care for conditions such as Alzheimer’s disease.
Advancing clinical MR imaging at 1.5T with high-gradient performance and deep learning
Following the introduction of the high-gradient 1.5T SIGNA Sprint Elite11 at ISMRM 2025, the system is now supporting advanced clinical applications in cardiology and oncology. Clinical teams have demonstrated its ability to deliver high-quality, time-efficient imaging in demanding healthcare settings.
At ISMRM 2026, GE HealthCare will showcase cardiac imaging cases from AZ Delta, highlighting how SIGNA Sprint Elite combines advanced gradient performance with deep learning–based reconstruction to enable faster and more consistent cardiac MR examinations.
“SIGNA Sprint Elite bridges the gap between high-performance cardiac MRI and scalable clinical practice,” said Dr. Kristof De Smet, PhD, Chairman of the Medical Board at AZ Delta, Belgium. “The system delivers high-quality imaging with significantly shorter acquisition times, making cardiac MR more accessible, efficient, and clinically impactful.”
These real-world clinical examples underscore GE HealthCare’s commitment to bringing advanced MR innovations into routine clinical practice, helping clinicians meet rising imaging demands while preserving image quality and diagnostic confidence
Discover more at ISMRM 2026
At ISMRM 2026, GE HealthCare will showcase these innovations and more, bringing together researchers, clinicians, and collaborators from around the world to explore the future of MR research and clinical imaging. For more information, visit the GE HealthCare booth #B17.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global provider of healthcare solutions, offering advanced medical technologies, pharmaceutical diagnostics, and AI-, cloud-, and software-enabled solutions that help clinicians address some of the world’s most complex diseases. With a 130-year legacy of serving patients and healthcare providers, GE HealthCare continues to drive innovation for the future of medicine through its Advanced Imaging Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses, enabling more personalized and precise patient care. The company is a $20.6 billion enterprise supported by approximately 54,000 employees worldwide, united by a vision to create a world where healthcare has no limits.
Contacts
GE HealthCare Media Contact:
Katie Scrivano
M +1 262-215-5281
Katherine.Scrivano@gehealthcare.com
